RG
Publicaties op Oncologisch.com
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer:...
Ipatasertib plus abiraterone bij mCRPC: IPATential150 fase III
Pembrolizumab plus axitinib versus sunitinib bij mRCC: KEYNOTE-426 42-maanden
Pembrolizumab plus axitinib versus sunitinib bij gevorderd niercelcarcinoom: KEYNOTE-426 fase III